Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 21, 2018 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma to Host Analyst and Investor Day on February 28, 2018

MALVERN, Pa., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
February 20, 2018 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Announces Publication of Supportive Phase II IV Meloxicam Bunionectomy Data in the Journal of Pain Research

MALVERN, Pa., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
February 02, 2018 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Announces Key Sales Team Additions

MALVERN, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
January 17, 2018 08:45 ET | Source: Recro Pharma, Inc.

Recro Pharma Announces Publication of Supportive Phase II IV Meloxicam Data in the Journal of Clinical Pharmacology

MALVERN, Pa., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
January 03, 2018 11:16 ET | Source: Recro Pharma, Inc.

UPDATE – Recro Pharma Announces Key Executive Promotions to the Financial Team

MALVERN, Pa., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
January 03, 2018 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Announces Key Executive Promotions to the Financial Team

MALVERN, Pa., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
December 29, 2017 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Reports Inducement Grants for New Staff

MALVERN, Pa., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
November 20, 2017 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Secures $100 Million Credit Facility

Proceeds Provide Funding for IV Meloxicam 30mg Approval Milestone Interest-only Structure Allows for Reinvestment of CDMO Cash Flows in Value Accretive Commercial Activities Substantial Reduction in...
November 09, 2017 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Reports Third Quarter 2017 Financial Results

NDA Submission for IV Meloxicam Accepted by U.S. FDA for Review; PDUFA Date Set for May 26, 2018 Strong Gainesville Manufacturing Performance; Third Quarter 2017 Revenues of $17.1 Million MALVERN,...
November 08, 2017 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma to Present at Upcoming Investor Conferences

MALVERN, Pa., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...